Latest news

May 23, 2022

Catalyst Biosciences Sells Complement Portfolio for $60 Million

May 09, 2022

Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

Mar 31, 2022

Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update

X